Cold Spring Harbor Laboratory, CompuCyte Corporation Establish Regional Quantitative Imaging Cytometry Center

Cold Spring Harbor, NY and Cambridge, Massachusetts -- CompuCyte Corporation and Cold Spring Harbor Laboratory (CSHL) today announced the establishment of the first U.S.-based Regional Quantitative Imaging Cytometry Center of Excellence. Located at CSHL and jointly run by the two organizations, the Center will provide educational and training resources for quantitative imaging cytometry (QIC) based on CompuCyte’s laser scanning technology (LSC).

“Quantitative Imaging Cytometry is an emerging area with extraordinary potential for cancer research,” stated Nicholas Tonks, Ph.D., FRS, Director of Shared Resources for the CSHL Cancer Center. “As an NCI-designated Cancer Center, CSHL strives to provide its researchers with the latest technologies to facilitate their work. CSHL’s partnership with CompuCyte gives our scientists full advantage of the power of this technology and will allow them to develop new applications for its use.”

Under the agreement, which extends and expands an existing relationship between the two organizations, CSHL and CompuCyte will sponsor an annual symposium and several training programs throughout the year, focusing on new QIC techniques for researchers using LSC systems in cell and tissue-based research. The Center will be guided by an advisory committee of renowned cytometry experts:

  • Zbigniew Darzynkiewicz, M.D., Ph.D., Director, Brander Cancer Research Institute, New York Medical College, Valhalla, NY
  • William Geddie, M.D., Department of Pathology, University Health Network and Assistant Professor, University of Toronto
  • James Jacobberger, Ph.D., Professor of Oncology, Associate Director for Shared Resources, Director: Cell Analysis Core, Case Comprehensive Cancer Center, Cleveland, OH
  • Gloria Juan, Ph.D., Sr. Scientist, Amgen, Thousand Oaks, CA
  • William Telford, Ph.D., Director, Core Flow Cytometry Resource, National Cancer Institute of the National Institutes of Health, Bethesda, MD

“CompuCyte’s laser scanning cytometry technology is the first technology on the market to combine quantitative measurement of cellular constituents with comprehensive imaging at various degrees of resolution, in a single powerful instrument,” said Dr. Elena Holden, CompuCyte’s President and CEO. “Our agreement with CSHL fills a critical need for advanced training and application development in the emerging discipline of quantitative imaging cytometry. CSHL’s unsurpassed reputation for life science research and education makes it a natural home for this Center.”

“Progress in cell biology is being driven by development of new analytical tools and methods,” explained Zbigniew Darzynkiewicz, Director of the Brander Cancer Center in Valhalla, NY.  “Cytometry instrumentation, including laser scanning cytometry, has immensely expanded analytical capabilities designed to probe individual cells and will be invaluable for further progress in cell research.”

CSHL is a private, non-profit research and education institution dedicated to exploring molecular biology and genetics in order to advance the understanding and ability to diagnose and treat cancers, neurological diseases, and other causes of human suffering.  For more information about CSHL visit www.cshl.edu.

CompuCyte Corporation, a private company headquartered in Cambridge, Massachusetts, is a leader in the development of cellular analysis instrumentation for life science research, drug safety, toxicology studies and clinical trials.  The company’s iCyte®, iCys®, and iColor™ cytometers enable quantitative cytometric image analysis of cellular and tissue specimens. For more information about the technology visit www.compucyte.com.